BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
POSTED
07-12-18
FRANKLIN LAKES, N.J., July 12, 2018 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support the company’s 2020 Sus...
POSTED
06-06-17
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2016 Sustainability Report.
BD’s sustainability strategy is driven by its purpose – advancing the world of health. The report describes BD’s progress against its 2020...
POSTED
09-22-16
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has published its 2015 Sustainability Performance Update report.
The report provides an update of BD’s global environmental, social and governance performance, against the company’s 2020 Sustainabi...
POSTED
05-23-12
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today the publication of its 2011 Sustainability Report. The report focuses on the Company’s shared-value approach to sustainability, which focuses on the relationship among strong economic perf...
POSTED
05-21-12
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Heart to Heart International, a humanitarian medical aid nonprofit organization, are teaming up for their second joint volunteer initiative to strengthen healthcare in Haiti. A team of 16 BD employees...
POSTED
06-09-11
/PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Heart to Heart International, a humanitarian medical aid nonprofit organization, announced a joint volunteer initiative to strengthen healthcare in Haiti. A team ...
POSTED
05-19-11
/PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2010 Sustainability Report. The report reaffirms the commitment of BD's 29,000 dedicated associates worldwide to pursu...
POSTED
03-21-11
/PRNewswire/ - In recognition of World TB Day, held each year on March 24, BD (Becton, Dickinson and Company) (NYSE: BDX) has launched an online campaign designed to increase access to improved diagnostics that are crucial in the ongoing fight against tuberculosis (TB).
...POSTED
03-15-11
/PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it is donating $325,000 to assist in relief efforts for victims of the earthquake and tsunami in Japan. BD will distribute these funds among nonpr...
POSTED
01-24-11
/PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Rady Children's Hospital-San Diego today announced that they have implemented an innovative pilot program at the Hospital that is designed to safely divert a signi...